High Tower Advisors, LLC Innoviva, Inc. Transaction History
High Tower Advisors, LLC
- $64.2 Billion
- Q2 2024
A detailed history of High Tower Advisors, LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 38,110 shares of INVA stock, worth $759,151. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38,110
Previous 38,590
1.24%
Holding current value
$759,151
Previous $588,000
6.29%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding INVA
# of Institutions
222Shares Held
78.9MCall Options Held
20KPut Options Held
5.4K-
Black Rock Inc. New York, NY9.63MShares$192 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT7.28MShares$145 Million20.14% of portfolio
-
Franklin Resources Inc San Mateo, CA6.62MShares$132 Million0.03% of portfolio
-
Putnam Investments LLC Boston, MA6.27MShares$125 Million0.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.18MShares$123 Million0.0% of portfolio
About Innoviva, Inc.
- Ticker INVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,706,000
- Market Cap $1.39B
- Description
- Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...